Literature DB >> 312171

Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.

J R Kateley, S J Bazzell.   

Abstract

The peripheral blood of twenty-eight patients with multiple sclerosis (MS) was examined for 'active' thymus (TA) derived lymphocytes (PBL) and the presence of serum factors which impair the lymphocyte blastogenic response and the migration of leucocytes from capillary tubes. MS patients exhibited a significant reduction in the level of circulating TA lymphocytes (15.2+/-2.7 vs 22.9+/-2.9, P less than 0.001). Additionally, MS serum markedly impaired the mobility and the mitogen induced blastogenic response of autologous and allogenic (control) PBL. Impairment in the blastogenic response was observed only when serum was added at culture initiation or after 4 hr. The results support the concept of a generalized deficiency in the immune competence of MS patients. The pathophysiological role of a serum suppressive factor is discussed.

Entities:  

Mesh:

Year:  1979        PMID: 312171      PMCID: PMC1537632     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Measles antibodies in multiple sclerosis.

Authors:  J M ADAMS; D T IMAGAWA
Journal:  Proc Soc Exp Biol Med       Date:  1962-12

Review 2.  Cellular immunity in multiple sclerosis.

Authors:  S C Knight
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

3.  Regulatory substances produced by lymphocytes--IV. Further characterization of the inhibitor of DNA synthesis (IDS).

Authors:  Y Namba; B H Waksman
Journal:  Immunochemistry       Date:  1977-02

4.  Lymphocytotoxic antibodies in multiple sclerosis.

Authors:  A L Schocket; H L Weiner; J Walker; K McIntosh; P F Kohler
Journal:  Clin Immunol Immunopathol       Date:  1977-01

Review 5.  Multiple sclerosis: a virus disease?

Authors:  K B Fraser
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

Review 6.  Epidemiology of multiple sclerosis.

Authors:  E D Acheson
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

7.  Measles virus antibodies in multiple sclerosis. Comparison of antibody titers in cerebrospinal fluid and serum.

Authors:  E Norrby; H Link; J E Olsson
Journal:  Arch Neurol       Date:  1974-04

8.  Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis.

Authors:  E Norrby; H Link; J E Olsson; M Panelius; A Salmi; B Vandvik
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

9.  Circulating immune complexes in multiple sclerosis and other neurological diseases.

Authors:  T G Tachovsky; R P Lisak; H Koprowski; A N Theofilopoulos; F J Dixon
Journal:  Lancet       Date:  1976-11-06       Impact factor: 79.321

10.  A suppression of cellular immunity in patients with multiple sclerosis.

Authors:  V Utermohlen; J B Zabriskie
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  1 in total

1.  On the role of sensitised T-lymphocytes in the pathogenesis of multiple sclerosis.

Authors:  A Turner; M L Cuzner; A N Davison; P Rudge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-04       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.